BBK Worldwide Blog

New survey findings reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.

Patients want options, or choice, when it comes to clinical trial participation. New data from a recent Study Voices survey reveals the impact choice can have on participation. The findings empower clinical trial sponsors to shift from traditional clinical trial enrollment models to hybrid enrollment models.

DOWNLOAD NOW

A Diversified Outreach Strategy
Is Key to Clinical Trial Inclusivity

New Infographic Available for Download

Many clinical trial sponsors are seeking ways to enable hybrid study designs with ease and confidence. Our new infographic follows the patient's journey from consideration to enrollment to engagement throughout the study life cycle, with information to help sponsors create a more diverse and inclusive participation environment.

We are all hoping that 2022 will be a better year for the world, one where the impact of the pandemic truly begins to subside for everyone around the globe. That said, it is a basic truth that every challenge presents some opportunity, and the impact of COVID-19 on the clinical research and development industry has been no exception.

We are very excited to kick off the new year with the announcement that we have been acquired by Publicis Health, the healthcare communications leader that transforms healthcare marketing and communications into healthcare engagement.

Together, we share a commitment to the clinical trial experience and to enhancing understanding and access for all, and we look forward to joining the Publicis Health network. Our mission remains unchanged, as does our commitment to supporting you in advancing your clinical R&D efforts.

The clinical trial landscape saw a lot of changes in 2021, from decentralized clinical trial adoption to a greater emphasis on diversity and inclusion. But what’s in store for 2022? We asked our industry experts to weigh in with their predictions.

New survey results and insights help clinical trial sponsors improve diversity and inclusion, enroll faster, and keep participants engaged longer.

When we developed our latest Study Voices survey, we expected to see large gaps in attitudes and experiences among healthcare consumers and clinical trial participants based on factors such as age, race, ethnicity, gender, and income – but that wasn’t the case.

Catch Up on Our Content for Clinical Trial Sponsors

Now is the perfect time to catch up on our most popular content of 2021!

Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial enrollment and engagement landscape.

The One Thing Every Sponsor Needs to Start a Decentralized Clinical Trial Off Right

I recently sat down with Chief Innovation Officer Rob Laurens to discuss how BBK's Engagement Solution Center solves many of the challenges sponsors face when planning and initiating a decentralized clinical trial. 

Earlier this week, Cellectar Biosciences, a late-stage clinical biopharmaceutical company focused on the discovery and development of targeted drugs for the treatment of cancer, announced its partnership with BBK to provide concierge services for patients participating in its clinical studies. The services are designed to improve patients' and their caregivers' access to high-quality care and innovative treatments for their cancer.

Earlier this week, BBK's Senior Director of Patient Engagement Services Mike Johnson spoke with Outsourcing-Pharma to discuss the RSG^® Arrive travel program and its recent milestone of 20,000 completed trips.

In this in-depth interview, Mike discusses what sets this program apart from others as he highlights the concierge specialists who are experienced in understanding all the ramifications of a request, as it relates not only to arranging a travel itinerary but also ensuring the itinerary supports patient health, safety, and compliance. In addition, Mike shares insight into the significance of the milestone for BBK as well as the industry at large. Click here to read the full article.